In the non-MEN1 syndrome group, 61 tumors from patients with sporadic parathyroid tumors (n = 30), MEN2A (n = 1), and hyperparathyroidism-jaw tumor (n = 1) were evaluated (Table 1). This evidence concerns the gene RET and hyperparathyroidism.